Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tullahoma, TN
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beaumont, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beaumont, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Galveston, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lubbock, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Odessa, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Odessa, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Midlothian, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Midlothian, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kirkland, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Madison, WI
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated:  12/31/1969
mi
from
Adrogué,
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
Status: Enrolling
Updated: 12/31/1969
mi
from
Adrogué,
Click here to add this to my saved trials
Database Registry of the Intermountain Heart Collaborative Study
Database Registry of the Intermountain Heart Collaborative Study
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Database Registry of the Intermountain Heart Collaborative Study
Database Registry of the Intermountain Heart Collaborative Study
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
OV-UCLA Medical Center
mi
from
Sylmar, CA
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
OV-UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated:  12/31/1969
Suburban Hospital
mi
from
Bethesda, MD
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated: 12/31/1969
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cardiovascular Disease Screening
Suburban/NHLBI Cardiovascular Disease Screening Protocol
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effect of Diet on Vascular Disease in Pre-Menopausal Women
The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Alaska Regional Hospital and Alaska Cardiovascular Research Foundation, LLC
mi
from
Anchorage, AK
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Alaska Regional Hospital and Alaska Cardiovascular Research Foundation, LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Glendale Memorial Hospital and Health Center
mi
from
Glendale, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Glendale Memorial Hospital and Health Center
mi
from
Glendale, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Hoag Memorial Hospital Presbyterian and Radin Inc.
mi
from
Newport Beach, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Hoag Memorial Hospital Presbyterian and Radin Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Catholic Healthcare West (d/b/a mercy General Hospital) and Regional Cardiology Associates
mi
from
Sacramento, CA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Catholic Healthcare West (d/b/a mercy General Hospital) and Regional Cardiology Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cardiovascular Associates
mi
from
Denver, CO
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cardiovascular Associates
mi
from
Denver, CO
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
University of Florida-Shands/Jacksonville
mi
from
Jacksonville, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
University of Florida-Shands/Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Orlando Regional Healthcare System
mi
from
Orlando, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Orlando Regional Healthcare System
mi
from
Orlando, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Cardiology Consultants of Northwest Florida
mi
from
Pensacola, FL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Cardiology Consultants of Northwest Florida
mi
from
Pensacola, FL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Northeast Georgia Heart Center
mi
from
Gainesville, GA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Northeast Georgia Heart Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Midwest Heart Foundation
mi
from
Lombard, IL
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Midwest Heart Foundation
mi
from
Lombard, IL
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital of Indiana and Northern Indiana Research Alliance of the Heart Center Medical Group
mi
from
Fort Wayne, IN
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital of Indiana and Northern Indiana Research Alliance of the Heart Center Medical Group
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
The Care Group, LLC
mi
from
Indianapolis, IN
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Kentucky Heart Institute / King's Daughter
mi
from
Ashland, KY
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Kentucky Heart Institute / King's Daughter
mi
from
Ashland, KY
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Baptist Healthcare System Inc. (d/b/a Central Baptist Hospital)
mi
from
Lexington, KY
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Baptist Healthcare System Inc. (d/b/a Central Baptist Hospital)
mi
from
Lexington, KY
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins
mi
from
Baltimore, MD
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
MedStar Research Institute (Washington Hospital Center)
mi
from
Hyattsville, MD
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
MedStar Research Institute (Washington Hospital Center)
mi
from
Hyattsville, MD
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
Advanced Cardiac Healthcare (Bronson Methodist Hospital)
mi
from
Kalamazoo, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
Advanced Cardiac Healthcare (Bronson Methodist Hospital)
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials